BIM
MYOV

Bogle Investment Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Bogle Investment Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-28,822
Closed -$594K – 345
2020
Q2 		$594K Buy
+28,822
New +$392K 0.1% 196

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NCM
NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Bogle Investment Management's MYOV Position: Q3 2020 in Review

Bogle Investment Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2020, closing a stake of 28,822 shares — an estimated $594K sold.

Bogle Investment Management first reported a position in MYOV in Q2 2020 and held it in 1 quarter. The position peaked at $594K in Q2 2020. 102 funds tracked by Wall St. Rank hold MYOV as of Q3 2020.

  • Bogle Investment Management reported no remaining Myovant Sciences Ltd. position as of Q3 2020 after selling out during the quarter.
  • Bogle Investment Management sold 28,822 Myovant Sciences Ltd. shares in Q3 2020, an estimated $594K.
  • Bogle Investment Management first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 1 quarter.
  • Bogle Investment Management's Myovant Sciences Ltd. position peaked at $594K in Q2 2020.
  • 102 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2020.

Based on Bogle Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.